No Apolipoprotein E (APOE) genotyping was performed on the study sample; however, given the E values calculated for the associations, APOE4 carrier status had to increase the risk of MCI by at least 1.77 in the presence of the other AD biomarkers to explain away the observed associations. Here, APOE is linked to Alzheimer disease.